Gladstone Institutional Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.99M | Buy |
37,184
+15,963
| +75% | +$1.71M | 0.17% | 142 |
|
|
2025
Q1 | $2.14M | Buy |
21,221
+14,680
| +224% | +$1.48M | 0.1% | 218 |
|
|
2024
Q4 | $584K | Sell |
6,541
-558
| -8% | -$49.8K | 0.03% | 435 |
|
|
2024
Q3 | $595K | Sell |
7,099
-198
| -3% | -$16.6K | 0.03% | 408 |
|
|
2024
Q2 | $562K | Buy |
7,297
+80
| +1% | +$6.16K | 0.03% | 403 |
|
|
2024
Q1 | $494K | Buy |
7,217
+3,077
| +74% | +$211K | 0.03% | 411 |
|
|
2023
Q4 | $239K | Buy |
+4,140
| New | +$239K | 0.01% | 577 |
|
|
2022
Q3 | – | Sell |
-6,929
| Closed | -$258K | – | 635 |
|
|
2022
Q2 | $258K | Sell |
6,929
-1,691
| -20% | -$63K | 0.02% | 543 |
|
|
2022
Q1 | $382K | Sell |
8,620
-2,874
| -25% | -$127K | 0.03% | 489 |
|
|
2021
Q4 | $488K | Buy |
11,494
+500
| +5% | +$21.2K | 0.04% | 385 |
|
|
2021
Q3 | $477K | Buy |
10,994
+5,787
| +111% | +$251K | 0.05% | 337 |
|
|
2021
Q2 | $223K | Buy |
+5,207
| New | +$223K | 0.03% | 467 |
|